Doege KJ, Sasaki M, Kimura T, Yamada Y (1991. január 1.). „Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms”. J. Biol. Chem.266 (2), 894–902. o. DOI:10.1016/S0021-9258(17)35257-2. PMID1985970.
Aspberg A (2012. december 1.). „The different roles of aggrecan interaction domains”. The Journal of Histochemistry and Cytochemistry60 (12), 987–96. o. DOI:10.1369/0022155412464376. PMID23019016. PMC3527881.
Chremos A, Horkay F (2023. szeptember 1.). „Coexistence of Crumpling and Flat Sheet Conformations in Two-Dimensional Polymer Networks: An Understanding of Aggrecan Self-Assembly”. Physical Review Letters131 (13), 138101. o. DOI:10.1103/PhysRevLett.131.138101. PMID37832020.
Nap RJ, Szleifer I (2008. november 1.). „Structure and interactions of aggrecans: statistical thermodynamic approach”. Biophys. J.95 (10), 4570–83. o. DOI:10.1529/biophysj.108.133801. PMID18689463. PMC2576360.
Chandran, PL (2012. január 1.). „Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications”. Acta Biomaterialia8 (1), 3–12. o. DOI:10.1016/j.actbio.2011.08.011. PMID21884828. PMC3226867.
Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB (2002. március 1.). „Structure and function of aggrecan”. Cell Res.12 (1), 19–32. o. DOI:10.1038/sj.cr.7290106. PMID11942407.
Roughley P, Martens D, Rantakokko J, Alini M, Mwale F, Antoniou J (2006). „The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage”. Eur Cell Mater11, 1–7; discussion 7. o. DOI:10.22203/eCM.v011a01. PMID16425147.
Sivan SS, Wachtel E, Roughley P (2014). „Structure, function, aging and turnover of aggrecan in the intervertebral disc”. Biochim. Biophys. Acta1840 (10), 3181–9. o. DOI:10.1016/j.bbagen.2014.07.013. PMID25065289.
Morawski M, Brückner G, Arendt T, Matthews RT (2012. május 1.). „Aggrecan: Beyond cartilage and into the brain”. The International Journal of Biochemistry & Cell Biology44 (5), 690–3. o. DOI:10.1016/j.biocel.2012.01.010. PMID22297263.
East CJ, Stanton H, Golub SB, Rogerson FM, Fosang AJ (2007). „ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan”. J. Biol. Chem.282 (12), 8632–40. o. DOI:10.1074/jbc.M605750200. PMID17255106.
nih.gov
pubmed.ncbi.nlm.nih.gov
Doege KJ, Sasaki M, Kimura T, Yamada Y (1991. január 1.). „Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms”. J. Biol. Chem.266 (2), 894–902. o. DOI:10.1016/S0021-9258(17)35257-2. PMID1985970.
Aspberg A (2012. december 1.). „The different roles of aggrecan interaction domains”. The Journal of Histochemistry and Cytochemistry60 (12), 987–96. o. DOI:10.1369/0022155412464376. PMID23019016. PMC3527881.
Chremos A, Horkay F (2023. szeptember 1.). „Coexistence of Crumpling and Flat Sheet Conformations in Two-Dimensional Polymer Networks: An Understanding of Aggrecan Self-Assembly”. Physical Review Letters131 (13), 138101. o. DOI:10.1103/PhysRevLett.131.138101. PMID37832020.
Nap RJ, Szleifer I (2008. november 1.). „Structure and interactions of aggrecans: statistical thermodynamic approach”. Biophys. J.95 (10), 4570–83. o. DOI:10.1529/biophysj.108.133801. PMID18689463. PMC2576360.
Chandran, PL (2012. január 1.). „Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications”. Acta Biomaterialia8 (1), 3–12. o. DOI:10.1016/j.actbio.2011.08.011. PMID21884828. PMC3226867.
Kiani C, Chen L, Wu YJ, Yee AJ, Yang BB (2002. március 1.). „Structure and function of aggrecan”. Cell Res.12 (1), 19–32. o. DOI:10.1038/sj.cr.7290106. PMID11942407.
Roughley P, Martens D, Rantakokko J, Alini M, Mwale F, Antoniou J (2006). „The involvement of aggrecan polymorphism in degeneration of human intervertebral disc and articular cartilage”. Eur Cell Mater11, 1–7; discussion 7. o. DOI:10.22203/eCM.v011a01. PMID16425147.
Sivan SS, Wachtel E, Roughley P (2014). „Structure, function, aging and turnover of aggrecan in the intervertebral disc”. Biochim. Biophys. Acta1840 (10), 3181–9. o. DOI:10.1016/j.bbagen.2014.07.013. PMID25065289.
Morawski M, Brückner G, Arendt T, Matthews RT (2012. május 1.). „Aggrecan: Beyond cartilage and into the brain”. The International Journal of Biochemistry & Cell Biology44 (5), 690–3. o. DOI:10.1016/j.biocel.2012.01.010. PMID22297263.
East CJ, Stanton H, Golub SB, Rogerson FM, Fosang AJ (2007). „ADAMTS-5 deficiency does not block aggrecanolysis at preferred cleavage sites in the chondroitin sulfate-rich region of aggrecan”. J. Biol. Chem.282 (12), 8632–40. o. DOI:10.1074/jbc.M605750200. PMID17255106.
ncbi.nlm.nih.gov
Aspberg A (2012. december 1.). „The different roles of aggrecan interaction domains”. The Journal of Histochemistry and Cytochemistry60 (12), 987–96. o. DOI:10.1369/0022155412464376. PMID23019016. PMC3527881.
Nap RJ, Szleifer I (2008. november 1.). „Structure and interactions of aggrecans: statistical thermodynamic approach”. Biophys. J.95 (10), 4570–83. o. DOI:10.1529/biophysj.108.133801. PMID18689463. PMC2576360.
Chandran, PL (2012. január 1.). „Aggrecan, an unusual polyelectrolyte: review of solution behavior and physiological implications”. Acta Biomaterialia8 (1), 3–12. o. DOI:10.1016/j.actbio.2011.08.011. PMID21884828. PMC3226867.